TABLE 1.
Controls | Re-transplant < 90 days |
p-value | |
---|---|---|---|
N | 26,696 | 90 | |
Recipient age (years) | 51.9 ± 11.9 | 48.6 ± 12.8 | 0.004 |
Donor age (years) | 31.2 ± 12.6 | 33.5 ± 13.1 | 0.96 |
Diabetic recipient | 5,339 (20.0%) | 14 (15.6%) | 0.23 |
Underweight (BMI < 18.5) | 952 (3.6%) | 6 (6.7%) | 0.10 |
Severely/Morbidly obese (BMI > 35) | 1,009 (3.8%) | 7 (7.8%) | 0.04 |
Recipient eGFR (mL/min/m2) | 52.5 ± 13.3 | 28.6 ± 25.3 | <0.001 |
Total bilirubin >2 dl/mg | 2,955 (11.1%) | 33 (36.7%) | < 0.001 |
Intubated | 727 (2.7%) | 53 (58.9%) | < 0.001 |
Inotropic support | 13,121 (49.1%) | 71 (78.9%) | < 0.001 |
Donor : Recipient weight <0.7 | 1,183 (4.4%) | 4 (4.4%) | 0.88 |
Transplant year | 2001.3 ± 4.1 | 2001.1 ± 3.7 | 0.59 |
IABP | 1402 (5.2%) | 27 (30.0%) | <0.001 |
ECMO | 84 (0.3%) | 14 (15.6%) | < 0.001 |
LVAD | 4,352 (16.3%) | 33 (36.7%) | < 0.001 |
RVAD | 33 (0.1%) | 2 (2.2%) | <0.001 |
BiVAD | 378 (1.4%) | 5 (5.6%) | 0.001 |
BiVAD: biventricular assist device, BMI: body mass index, ECMO: extracorporeal membrane oxygenation, eGFR: estimated glomerular filtration rate, IABP: intra-aortic balloon pump, LVAD: left ventricular assist device, MCS: mechanical circulatory support, RVAD: right ventricular assist device